1 
100 
Christine Oliver is the next speaker. 
DR. OLIVER: My name is Christine Oliver. I 
3 am a physician, board-certified in internal medicine, 
4 and a Clinical Associate in the Department of Medicine 
5 at the Massachusetts General Hospital in Boston, Massa- 
6 chusetts. I also have a Master of Public Health degree 
I in occupational health from the Harvard School of Public 
8 Health. I am currently working with the Oil, Chemical 
g and Atomic Workers International Union. I am speaking 
10 today as a representative of the union and for the union. 
II I will address today the issue of recombinant 
12 DNA research as a threat to the collective and individual 
13 health of the potentially exposed worker, and the proposed 
14 revised NIH guidelines as they relate to that threat. I 
15 will attempt to put the issue into perspective by discus- 
16 sing briefly the health and safety situation as it currently 
17 exists in many other work environments. 
18 During the past eight weeks I visited five 
19 industrial plants whose workers are members of the OCAW 
20 to assess the health hazards in these plants. These 
21 plants include chemical plants in New Jersey and Louisiana, 
22 oil refineries in Louisiana, a pesticide plant in Tennessee, 
23 and a chemical pesticide plant in Illinois. Each employs 
24 at least 150 production workers. Each is subject to OSHA 
25 regulations, and in each plant the workers are represented 
[192] 
